AMCI - Amnestic Mild Cognitive Impairment: Clinical Trials

4 trials for AMCI - Amnestic Mild Cognitive Impairment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 active not recruiting. 2 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Recruiting 1
Phase 21Recruiting 1

Follow AMCI - Amnestic Mild Cognitive Impairment: new trials by email Literature Review of AMCI - Amnestic Mild Cognitive Impairment trials Research Report on AMCI - Amnestic Mild Cognitive Impairment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment
Active transcranial Photobiomodulation, sham transcranial Photobiomodulation, Cognitive Rehabilitation - AMCI - Amnestic Mild Cognitive Impairment
Not applicableRecruitingUskudar University602024-03-302025-12-17
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
Trazodone, Placebo - AMCI - Amnestic Mild Cognitive Impairment, Sleep Disturbance
Phase 2RecruitingJohns Hopkins University1002023-02-022026-06-17
Neurocognitive Assessment Platform 4 Alzheimer
MCI, MCI Conversion to Dementia
RecruitingIRCCS San Raffaele1002021-12-152026-01-22
Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI
Simultaneous aerobic and cognitive training (SIM), Sequential aerobic and cognitive training (SEQ) - Mild Cognitive Impairment (MCI), AMCI - Amnestic Mild Cognitive Impairment
Not applicableActive not recruitingIRCCS San Raffaele552019-04-052025-01-10

Narrower conditions

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Neurodegenerative Diseases (1)  ·  Parasomnias (1)

Broader conditions

Mental Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurocognitive Disorders (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Dementia (1)  ·  Neurodegenerative Diseases (1)  ·  Sleep Wake Disorders (1)  ·  Tauopathies (1)

Interventions

Cognitive Training (2)  ·  Trazodone (1)

Sponsors

IRCCS San Raffaele (2)  ·  Johns Hopkins University (1)  ·  Uskudar University (1)

Countries

Italy (2)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Baris Metin, Prof. Dr. (1)  ·  Barry Greenberg, PhD (1)

Results publications

PMID 39422935

NIH funding

R01AG071522 (1)